Anika Klaus

Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

Caroline von Spee-Mayer, Elise Siegert, Dimas Abdirama et al. · Annals of the Rheumatic Diseases · 2015 · 325 citations

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing

Lena Andersch, Josefine Radke, Anika Klaus et al. · BMC Cancer · 2019 · 63 citations · Full text

Cell Therapy, Gd2-specific Car-t Cells, Vitro Testing +8

A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization

Laura Grunewald, Tobias Lam, Lena Andersch et al. · Frontiers in Immunology · 2021 · 53 citations · Full text

CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus

Ana Textor, Laura Grunewald, Kathleen Anders et al. · Cancers · 2021 · 36 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Car Design +15

Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4+ CAR T Cell Efficacy

Solin Ali, Karin Toews, Silke Schwiebert et al. · Frontiers in Immunology · 2020 · 35 citations · Full text